Elizabeth Perdeaux

Elizabeth Perdeaux's work experience includes being a Scientific Director for Patient Partnerships at Envision Pharma Group since 2022. Prior to that, they worked at Oxford PharmaGenesis from 2015 to 2022, where they held various roles such as Communications Team Leader, Communications Consultant, Senior Medical Writer, and Medical Writer. From 2012 to 2014, Elizabeth was a Charity Officer at Myrovlytis Trust, a medical research charity focused on rare hereditary kidney cancer syndromes. Before that, they were a Post-Doctoral Research Fellow at the Institute of Cancer Research from 2010 to 2012.

Elizabeth Perdeaux obtained a Bachelor's Degree in Genetics from the University of Cambridge from 2001 to 2004. Elizabeth continued their education at the same institution, completing a Master's Degree in Mammalian Genetics (MPhil) from 2004 to 2005. Elizabeth then pursued a Doctor of Philosophy (Ph.D.) in Developmental Genetics at the University of Cambridge, where they studied from 2005 to 2009. In addition to their formal education, Elizabeth obtained a certification in Coaching Skills for Leaders and Managers from LinkedIn in June 2021.